Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137

Site search

Correspondence address
310 Mira Street, Stavropol, Russia, 355017

+7 8652 352524; +7 8652 353229.

+7 8652 352524.


Folow up of skin testing with inhalation allergens in patients with comorbid allergic bronchial asthma and allergen-specific immunotherapy

[Internal diseases]
Elena Nadia; Valeriy Sovalkin; Galina Nechaeva; Ekaterina Loginova; Victor Goltyapin;

To assess the effect of allergen-specific immunotherapy (ASIT) on the parameters of specific allergic diagnostics with non-infectious allergens in patients with moderate allergic bronchial asthma, comorbid with allergic rhinitis and atopic dermatitis in the presence of polyvalent sensitization, a prospective, randomized controlled trial was conducted with 132 patients included. The first group of patients (n=88) against the background of basic anti-inflammatory therapy during the 3-year period had ASIT by four types of allergens identified during specific skin testing; the second group of patients (n=44) received only basic anti-inflammatory therapy. Analysis of the dynamics of the severity of skin-allergic samples showed that patients in the 1st group had significantly lower levels of pronounced tests and significant tests with an increase in the number of negative test results (p<0.005). By the end of the third year of observation, in the 2nd group of patients, the dynamics
towards a decrease in skin sensitivity to allergens was not detected.


1. Vorob’eva O. V., Gushchin I. S. Controlled studies of the efficacy and safety of allergen-specific immunotherapy: a historical aspect. Rossijskij allergologicheskij zhurnal. – Russian Allergology journal. 2011;4:3-14. (In Russ.).
2. Vyhristenko L. R. Sublingual and oral methods of specific immunotherapy for allergic diseases. Immunologiya, allergologiya, infektologiya. – Immunology, Allergology, Infectology. 2008;4:23-31. (In Russ.).
3. Gushchin I. S., Kurbacheva O. M. Allergiya i allergenspecificheskaya immunoterapiya. M.: «Farmarus Print Media», 2010. (In Russ.). https://doi.org/10.21518/2079-701X-2013-3-2-10-19
4. Kozulina I. E., Pavlova K. S., Kurbacheva O. M. Clinical efficacy of subcutaneous and sublingual allergenspecific immunotherapy of allergic rhinitis and conjunctivitis. Rossijskij allergologicheskij zhurnal. – Russian Allergology journal. 2016;6:63- 69. (In Russ.).
5. Pavlova K. S., Kurbacheva O. M. Pathogenetic therapy of allergic diseases: possibilities of ASIT in Russia. Effektivnaya farmakoterapiya. Allergologiya i immunologiya. – Effective pharmacotherapy. Allergology and immunology. 2012;2:10-15. (In Russ.).
6. Fedosova L. B., Pyckij V. I., Filatov O. Yu. Effektivnost’ specificheskoj allergovakcinacii u bol’nyh s razlichnym sochetaniem immunnyh i neimmunnyh mekhanizmov razvitiya atopii. Allergologiya i immunologiya. – Allergology and immunology. 2003;4(3):104-115. (In Russ.).
7. Calderón M., Cardona V., Demoly P. EAACI 100 Years of Immunotherapy Experts Panel. One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions. Allergy. 2012;67(4):462-476. https://doi.org/10.1111/j.1398-9995.2012.02785.x
8. Dreborg S. Evaluation of allergen immunotherapy. J. Allergy Clin. Immunol. Pract. 2015;3(2):267-268. https://doi.org/10.1016/j.jaip.2014.12.003
9. Jutel M., Agache I., Bonini S. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J. Allergy Clin. Immunol. 2016;137(2):358-368. https://doi.org/10.1016/j.jaci.2015.12.1300
10. Jutel M., Agache I., Bonini S. International consensus on allergy immunotherapy. J. Allergy Clin. Immunol. 2015;136(3):556-568. https://doi.org/10.1016/j.jaci.2015.04.047
11. Radulvic S., Calderon M. A., Wilson D. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst. Rev. 2010;8(12):CD002893. https://doi.org/10.1002/14651858.7
12. Wyrzykowska N., Czarnecka-Operacz M., Adamski Z. Long-term efficacy of allergen specific immunotherapy in atopic dermatitis patients in relation to quality of life. Eur. Ann. Allergy Clin. Immunol. 2015;47(1):5-9. https://doi.org/10.1186/2045-7022-5-s1-p6

Keywords: bronchial asthma, allergic rhinitis, dermatitis, allergy, comorbidity, allergen-specific immunotherapy, antiinflammatory therapy, skin tests

Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy